Applications | LabRulez ICPMS

Validating performance of an Agilent ICP‑MS for USP <232>/<233> & ICH Q3D(R2)/Q2(R1)

Applications

| 2022 | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Analysis of Artificial Tear Eye Drops For Elemental Impurities

Applications

| 2022 | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Analysis of Elemental Impurities in Synthetic Oligonucleotides by ICP-MS

Applications

| 2023 | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Analysis of Elemental Impurities in Oral Drug Products Using ICPMS-2040/2050 ―ICH Q3D

Applications

| 2023 | Shimadzu

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Determination of Extractable and Leachable Elements Using ICP-MS

Applications

| 2022 | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Validation of quantitative method for determination of elemental impurities in pharmaceutical products following USP 232/233 on ICPMS-2030

Applications

| 2019 | Shimadzu

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Analysis of ICH Q3D Guideline for Elemental Impurities in Drug Products Using ICPMS-2030

Applications

| 2016 | Shimadzu

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Analysis of elemental impurities in pharmaceutical products in accordance with USP General Chapters <232> and <233>

Applications

| 2022 | Thermo Fisher Scientific

ICP/MS, ICP/OES

Instrumentation

ICP/MS, ICP/OES

Manufacturer

Thermo Fisher Scientific

Industries

Pharma & Biopharma

Validation of Analysis Method Using ICPMS-2030 Based on USP <233> ELEMENTAL IMPURITIES - PROCEDURES

Applications

| 2020 | Shimadzu

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

The determination of the palladium content in valacyclovir hydrochloride using an Agilent 720 ICP-OES according to USP 35

Applications

| 2013 | Agilent Technologies

ICP/OES

Instrumentation

ICP/OES

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Applications | LabRulez ICPMS

Validating performance of an Agilent ICP‑MS for USP <232>/<233> & ICH Q3D(R2)/Q2(R1)

Analysis of Artificial Tear Eye Drops For Elemental Impurities

Analysis of Elemental Impurities in Synthetic Oligonucleotides by ICP-MS

Analysis of Elemental Impurities in Oral Drug Products Using ICPMS-2040/2050 ―ICH Q3D

Determination of Extractable and Leachable Elements Using ICP-MS

Validation of quantitative method for determination of elemental impurities in pharmaceutical products following USP 232/233 on ICPMS-2030

Analysis of ICH Q3D Guideline for Elemental Impurities in Drug Products Using ICPMS-2030

Analysis of elemental impurities in pharmaceutical products in accordance with USP General Chapters <232> and <233>

Validation of Analysis Method Using ICPMS-2030 Based on USP <233> ELEMENTAL IMPURITIES - PROCEDURES

The determination of the palladium content in valacyclovir hydrochloride using an Agilent 720 ICP-OES according to USP 35

Related content

We are trying to succeed with the spin-off company Galochrom

V4+ Conference on Environment and Health in Central Europe

Detecting nanoplastics – in fractions of a second